| 【Company Research】J&T Express (1519 HK) - Adjusted net loss in 2023 less than expected; ASP beat in China market but miss in SEA |
| 【Company Research】Meituan (3690 HK) - Expect significant loss reduction for new businesses |
| 【Company Research】Prudential Plc. (2378 HK) - NBP beat driven by better 2H margin; expect FY24 DPS to continue growing by 7%-9% |
| 【Company Research】Innovent Biologics (1801 HK) - More than obesity |
| 【Company Research】Intron Tech (1760 HK) - FY23 mostly in-line; Expect easing headwinds in FY24E |
| 【Company Research】FriendTimes (6820 HK) - Eyes on mini-game potential and cost control |
| 【Company Research】Sunny Optical (2382 HK) - Expectations reset on conservative guidance; Maintain HOLD |
| 【Company Research】Li Ning (2331 HK) - Expectations reset with positive initiatives |
| 【Company Research】CSPC Pharmaceutical (1093 HK) - New products to contribute meaningful revenue in 2024 |
| 【Company Research】Kuaishou (1024 HK) - More bullish on margin improvement |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
